News About: Pharm. Industry
Boehringer Ingelheim Korea to celebrate 30 years anniversary.
Boehring Ingelheim Korea where was highly praised as one of the best model management cases contributed to the Korean people's health and economy will celebrate its 30 year anniversary on March 8.
In the anniversa...
GSK to resume Avandia-Avandamet supply in early March.
GSK will supply two diabetic drugs, Avandia and Avandamet again from the early of March, which had not been smoothly supplied.
GSK said on Feb. 20 that the product supply delay was due to the adoption of new shipp...
Recent price slash critically to damage eye drug makers.
The recent government drug price cut on 1,477 products will seriously batter the drug makers for eye drugs and foreign multinational drug corporations.
Alcon Korea, an eye drug specialized foreign company in Korea,...
'First Brand Grand Prix' for Ketotop, arthritis pain killer.Ketotop, a topical pain killer patch produced and sold by Pacific Pharm. has been selected for "First Brand Grand Prix" in the area of the adhesive arthritis therapy by the Kore...
|
Drug company stock prices now in brisk aspect.
The leading security companies including Daesin, Hanwha and Goodmorning Shinhan have predicted an optimistic future for the stock prices of major pharmaceutical companies after passing through a long dark tunnel start...
Dongsung to enter Indian market with hair dyes.
Dongsung has led the hair dye business in Korea and now successfully extended its business to India in association with Kamakhya Inc. under the distribution agreement. They
already made an initial shipment for $30,0...
Maxmarvil sales on the rise with added indications.
Yuyu has changed the label of Maximarvil, an anti-osteoporosis drug, in which the patient may allow to lie down after medication of Maximarvil, which may increase its sales in such a severe market competition with man...
Sudo made profits and 82% sales growth in 2005.
Sudo pharmaceutical co. announced the 2005 business performance on Feb. 13 covering 32,200 million won of sales, 16,600 million won of gross profits, 3,800 million won of operating income and 2,500 million won of net ...
Il Yang successfully completed Ilaprazole clinical study in China.
Il Yang announced on Feb. 20 that the phase III clinical study for the anti-peptic ulcer drug, Ilaprazole in China was fully completed and ready to file the NDA for the commercial release hopefully in coming March thr...
Stiefel Korea to launch Duac gel for acne therapy.Stiefel Korea has launched Duac gel, a new hydro gel type of acne therapy, formulating with 1% of clindamycin and 5% of benzoylperoxide, which is the top prescription drug for a...
|
